No To Erlotinib PDF Print E-mail
Written by Laure James - Editor Pharmacy in Focus   
Wednesday, 07 July 2010 08:29
NICE has been unable to recommend erlotinib as a maintainence treatment for people with non small cell lung cancer who have had first line treatment and their disease has remained stable. Around 38,000 people are diagnosed with lung cancer every year in the UK.